Outcomes of Geriatric Patients Receiving CD19 Directed CAR-T Therapy: A Single Institution Study

Key Points

• Geriatric patients receiving CD19 directed CAR-T therapy showed positive clinical outcomes, enhancing treatment options.
• In this study, overall survival rates improved, with 70% of patients achieving a significant response.
• Assessment involved retrospective data analysis from a single institution, focusing on patient characteristics and treatment responses.
• This highlights the importance of exploring CAR-T therapy in older adults, a population often underrepresented in clinical trials.